Anxiety and Depression in COPD; Prevalence, Detection and Prognosis
NCT ID: NCT04427579
Last Updated: 2020-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2018-06-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The prevalence of anxiety and depressive disorders in patients with COPD
* The screening properties of Hospital Anxiety and Depression Scale in patients with COPD
* The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder.
* whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China
NCT03187236
COPD Assessment Test Can Predict Depression
NCT01727219
Symptom Clusters and Immune Markers in Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Longitudinal Study
NCT01016587
Prevalence and Predictors of Depression in COPD
NCT02415140
Disability and Health Outcomes in COPD
NCT00087906
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of COPD
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
LHL Hospital Gardermoen
UNKNOWN
Priory Hospital Altrincham
UNKNOWN
University Hospital, Akershus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gunnar Einvik
Post-doc candidate, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gunnar Einvik, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Akershus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LHL-hospital Gardermoen
Jessheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.